Deal Details

InMode Completes $77.0 Million Initial Public Offering

Healthcare

InMode initial public offering

Summary

InMode Ltd. ("InMode” or the "Company”) (NASDAQ-GS: INMD) recently completed an initial public offering of 5,500,000 shares of common stock (including exercise of the overallotment option) at a price of $14.00 per share, generating gross proceeds of $77.0 million. The Company intends to use the net proceeds from the offering to expand sales and marketing operations, continue research and development, fund strategic acquisitions and for general corporate purposes.

Baird served as a co-manager on this offering.

About

InMode is a leading global provider of innovative medical technologies that develops, manufactures and markets devices harnessing novel radio-frequency (RF) technology. The Company strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted, minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. The Company is based in Lake Forest, California, and Yokneam, Israel.